. 2024 Jan 29;15:1334308. doi: 10.3389/fpsyg.2024.1334308

Table 4.

Factors associated with poor quality of life (n: 47) in early IBD.

		Univariate analysis			Multivariate analysis
	IBDQ32 < 160/total n low IBDQ/n total (%)	OR	95% confidence interval	p	Adjusted OR	95% confidence interval	p
Sex
Women	30/69 (43.5)	3.17	1.55–6.46	0.001	3.04	1.39–6.53	0.005
Men	17/87 (19.5)	1	1.55–6.46	0.001	3.04	1.39–6.53	0.005
Disease type
CD	34/80 (42.5)	3.58	1.7–7.5	0.001	1.64	0.6–4.49	0.332
UC	13/76 (17.1)	1	1.7–7.5	0.001	1.64	0.6–4.49	0.332
BMI
<25	33/88 (37.5)	1	0.2–0.89	0.022	0.7	0.31–1.59	0.402
≥25	14/68 (20.6)	0.43	0.2–0.89	0.022	0.7	0.31–1.59	0.402
Use of mesalazine
Yes	25/110 (22.7)	0.321	0.15–0.67	0.002	0.51	0.19–1.4	0.194
No	22/46 (47.8)	0.321	0.15–0.67	0.002	0.51	0.19–1.4	0.194
Use of steroids
Yes	38/104 (36.5)	2.75	1.2–6.25	0.014	1.76	0.69–4.46	0.230
No	9/52 (17.3)	1	1.2–6.25	0.014	1.76	0.69–4.46	0.230
SRRS ≥ 150
Yes	43/120 (35.8)	4.47	1.48–13.48	0.005	3.55	1.08–11.6	0.036
No	4/36 (11.1)	1	1.48–13.48	0.005	3.55	1.08–11.6	0.036

Only variables significantly related with impairment in quality of life in the univariate analysis are included in this table. CD, Crohn’s disease; UC, Ulcerative colitis; BMI, Body mass index; IBDQ, Quality of life questionary for IBD; and SRRS, Social readjustment rating scale. Bold values indicate statistical significance at the p < 0.05 level.